As mpox cases rise globally, many Americans at high risk of contracting the virus are struggling to access the Jynneos vaccine due to its high cost and gaps in insurance coverage, The New York Times reported Nov. 4.
Here are five things to know:
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
